In contrast to the United States, Japanese patients with chronic hepatitis C currently treated
with interferon are generally 10 to 15 years older. Older patients, however, tend to …

AIM: To assess the extent of micronutrient and oxidative stress in blood and to examine their
linkages with viral loads in chronic hepatitis C patients. METHODS: Hepatitis C virus (HCV) …

BACKGROUND & AIMS: Antiviral treatment for hepatitis C virus (HCV) has high efficacy
rates for achieving sustained viral response (SVR) in randomized controlled trials (RCTs)(40 …

Purpose To investigate the ability of texture analysis of MRI images to stage liver fibrosis.
Current noninvasive approaches for detecting liver fibrosis have limitations and cannot yet …

Randomized controlled trials of hepatitis C virus (HCV) therapy with pegylated interferon
and ribavirin have demonstrated sustained viral response rates (SVRs) of 54 …

Estimated hepatitis C virus (HCV) infection rates in the general populations were 1.3, 0.9,
0.4–1.0, 14.7, 0.1–0.3, 0.9–1.9, 1.0–2.0, 5, 4.4–8.6 and 0.5–1.3% in Australia, Bangladesh …

The management of chronic viral hepatitis has changed significantly with the availability of
effective antiviral agents. There is now a high probability that timely intervention can arrest …

OBJECTIVES:: To evaluate the effects of zinc supplementation on serum zinc and copper
levels, and the severity of adverse reactions and virologic responses in chronic hepatitis C …

Objective: To determine hepatitis C (HCV) treatment effectiveness and predictors of
response in the “real‐world” Australian clinic setting. Design, setting and participants …

The combination of pegylated‐interferon (PEG‐IFN)/ribavirin is currently the standard of care
antiviral treatment for chronic hepatitis C (CHC), but optimal results require an individual …